Whose endo regularly suggests you get a GlycoMark test? Wait, better question: who has the slightest idea what constitutes “in range” for the GlycoMark test, or what the heck you’re supposed to do with the results?
Yeah, I thought so… me neither.
We’ve mentioned GlycoMark a few times here at the ‘Mine, but when it recently came up in conversation, our team basically all looked at each other and shrugged. This year’s ADA Conference seemed…
Read more »
Sometimes, diabetes science confuses me.
Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not.
Sodium-glucose transporter (SGLT-2) inhibitors increase insulin production and effectiveness and stop the liver from producing too much glucose. Basically, they work by spilling glucose over into the urine which leads to less sugar in your bloodstream. The effect: lower BGs and A1Cs.
Sure, it…
Read more »
Happy Saturday! You may experience a little deja vu on this one, as it’s a topic we addressed back in December 2011… about dealing with weight struggles.
Got the dieting blues on these Weighty Matters? We hear you. Please take a gander at this week’s edition of Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
Tim from Washington,…
Read more »
Even though her eyes were clouded with cataracts, Mrs. Romero’s gaze was steady, leaving no room for ambiguity. No room for argument. “I won’t take insulin,” she said firmly, “I don’t care if I die.” Period. End of discussion. At 85-years-of-age, my patient was joining the ranks of a new movement: elderly patients who refuse to take medications ordered by their doctors.
Isolated incidents or the cusp of a new trend? Just how big is…
Read more »